$7990 | SAVE $1,410 | Site License
$17850 | SAVE $3,150 | Global License

Europe Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares by Test, Strategies, Country Volume and Sales Segment Forecasts

Europe Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares by Test, Strategies, Country Volume and Sales Segment Forecasts
[Lowest Price Guaranteed: $7,990]

Published by Venture Planning Group (VPG): 01 Jul 2016 | 59299 | In Stock
Related Topics: Antibodies , Molecular Diagnostics , Office , Public Health

Introduction

Complete report ,400.  DataPack (test volumes, sales forecasts, supplier shares) ,100.

This new 363-page report from VPG Market Research provides analysis of the European enteric disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 

About this Report

This report presents detailed analysis of the Enteric Disease market in Europe (France, Germany, Italy, Spain, UK).  Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales forecasts and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used 
        for enteric disease testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in Europe.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 363 pages and 71 tables

 

Table of Contents
for Europe Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares by Test, Strategies, Country Volume and Sales Segment Forecasts

  • Table of Content - click REQUEST A SAMPLE BUTTON

List Of Tables
in Europe Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares by Test, Strategies, Country Volume and Sales Segment Forecasts

Competitive Assessments

- Abbott

- Affymetrix

- Beckman Coulter/Danaher

- Becton Dickinson

- bioMerieux

- Bio-Rad

- Cepheid

- Diamedix

- DiaSorin

- Eiken Chemical

- Elitech Group

- Enzo Biochem

- Fujirebio

- Grifols

- Hologic/Gen-Probe

- ID Biomedical/GSK

- Kreatech/Leica

- Lonza

- Ortho-Clinical Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Takara Bio

- Thermo Fisher/Life Technology

- Wallac/PE

- Wako

Additional Details

Publisher

Venture Planning Group (VPG)

Publisher Information

Reference

59299 | VPID19339

Number of Pages

363

Report Format

PDF

Venture Planning Group (VPG) Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Pentax Europe GmbH - Medical Equipment - Deals and Alliances Profile
SummaryPentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corporation is a research based med...
15 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Astellas Pharma Europe Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAstellas Pharma Europe Ltd (Astellas Pharma), a subsidiary of Astellas Pharma Inc. is a pharm...
09 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Pentax Europe GmbH - Medical Equipment - Deals and Alliances Profile
SummaryPentax Europe GmbH (Pentax Medical), a subsidiary of Hoya Corporation is a research based med...
25 Feb 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Fujirebio Europe N.V. - Strategic SWOT Analysis Review
Fujirebio Europe N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the com...
19 Jan 2016 by Global Data USD $106 (normally
USD $125)
More Info
SAVE 15% today! Bespak Europe Ltd. - Product Pipeline Analysis, 2015 Update
SummaryBespak Europe Ltd. (Bespak) is a medical device company. It supplies drug delivery devices fo...
17 Dec 2015 by Global Data USD $638 (normally
USD $751)
More Info
SAVE 15% today! Physician Views: As off-label Avastin use threatens to increase in Europe, where next for wet AMD therapies?
Scope The market for wet age-related macular degeneration (AMD) therapies retains significant commer...
16 Jul 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Oncology Market Access Europe – Payer and Industry Perspectives
IntroductionOncology Market Access Europe – Payer and Industry Perspectives answers your questions:W...
03 Jul 2014 by FirstWord Pharma USD $846 (normally
USD $995)
More Info
SAVE 15% today! The Reality of Market Access in Europe: the role of Health Technology Assessment
IntroductionFaced with slipping or negligible GDP growth and an economic crisis, Eurozone countries ...
10 Mar 2014 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: As Tecfidera approaches a critical juncture in Europe, how are neurologist perceptions towards Biogen Idec's MS drug shaping up?
ScopeSales of Biogen Idec’s multiple sclerosis therapy Tecfidera may continue to exceed initial expe...
01 Nov 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info
SAVE 15% today! Physician Views: Biosimilar Remicade poised for approval in Europe – are rheumatologists and gastroenterologists ready?
ScopeThe recent recommendation to approve a biosimilar version of Merck & Co./Johnson & Johnson's Re...
01 Jul 2013 by FirstWord Pharma USD $591 (normally
USD $695)
More Info

This report is published by Venture Planning Group (VPG)

Download Free Report Summary PDF

Europe Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares by Test, Strategies, Country Volume and Sales Segment Forecasts | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...